Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesWhich Biomarker is Useful to Evaluate as a Treatment Outcome in Spondyloarthritis
Current Rheumatology Reviews, 09/10/09
Lee S–H et al. – Although the etiology of ankylosing spondylitis is unknown, it is necessary to develop tools for evaluating the patient response to the new therapeutic drugs. AS is mediated by chronic inflammation and characterized by bone destruction and formation. This review discusses the recent studies suggesting candidate biomarkers for evaluation of the response to treatment and the joint remodeling markers.
Related Articles
Clinical assessment and outcome research in spondyloarthritis
Current Rheumatology Reports, 10/14/09
Relevance Score: 85%
Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS), and clinical and magnetic resonance imaging measures of disease activity in a 1 year follow-up study of patients with axial spondyloarthritis treated with TNF-alpha inhibitors
Annals of Rheumatic Diseases, 10/01/09
Relevance Score: 80%
Today in Spondylarthropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
An epidemiological survey of low back pain and axial spondyloarthritis in a Chinese Han population
Scandinavian Journal of Rheumatology , 11/24/09
The chromosome 16q region associated with ankylosing spondylitis includes the candidate gene TRADD (TNF receptor type 1-associated death domain)
Annals of Rheumatic Diseases, 11/13/09
Sponsor
Article Search
Sponsor